20Slash20 Inc., the creator of The Eye Drink, announced that it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, in New York City. CEO Dr. Roger Wu will deliver an investor presentation on Sept. 9 at 9:35 a.m. ET at The Westin New York Grand Central, and will also hold one-on-one meetings with investors during the event.
The conference is designed to bring together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for innovative companies to showcase their potential. For 20Slash20, this marks a significant opportunity to present its unique product to a targeted audience of investors and industry experts.
20Slash20’s flagship product, The Eye Drink, is described as the world’s first ready-to-drink functional beverage formulated specifically with science-backed ingredients to support eye health. The beverage targets individuals who spend extended hours daily on cellphones or computers, aiming to protect their eyes from screen-induced problems. The company positions The Eye Drink as a convenient and tasty solution to support eye health in today’s screen-centric world.
The announcement comes at a time when digital device usage continues to rise, leading to increased concerns about eye strain and related issues. According to the company, the product addresses a growing need among consumers who are seeking proactive health solutions. By participating in the conference, 20Slash20 aims to raise awareness among potential investors and partners about the market potential of its product.
The presentation is expected to cover the company’s business model, market strategy, and growth plans. Dr. Wu’s background and expertise will likely be highlighted, given his role as CEO and the company’s focus on science-backed formulation.
The conference also provides a networking platform where 20Slash20 can connect with other industry players and investors, potentially opening doors for future collaborations and funding opportunities. This exposure is crucial for a company in the functional beverage space, which is competitive and rapidly evolving.
For more information about 20Slash20 and The Eye Drink, interested parties can visit the company’s website. The full press release is available at https://ibn.fm/tm2lT.
About 20Slash20 Inc.: 20Slash20 has created The Eye Drink, the world’s first ready-to-drink functional beverage formulated specifically using science-backed ingredients for anyone who spends extended hours daily on their cellphones or computers to protect their eyes from screen-induced eye problems. It’s a convenient and tasty solution to support eye health in today’s screen-centric world.
About InvestorWire: InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; article and editorial syndication to 5,000+ outlets; enhanced press release enhancement to ensure maximum impact; social media distribution via IBN to millions of social media followers; and a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge. For more information, please visit https://www.InvestorWire.com.
